A Daily Telegraph investigation published on 9 May 2026 has revealed that almost half of NHS hospitals are using nurses to cover doctors’ shifts, highlighting growing pressure across the NHS workforce. For UK patients facing long NHS waits and rising private healthcare costs, the findings reinforce the case for faster consultant-led treatment abroad through MMG, with fixed-price surgery packages, accredited European hospitals and treatment available within weeks of diagnostic clearance.
Growing NHS waiting lists, doctor shortages and rising UK private healthcare costs are driving increasing numbers of British patients to seek faster consultant-led treatment abroad. New findings published by The Daily Telegraph on 9 May 2026, in an investigation by Janet Eastham, have placed renewed focus on staffing pressures inside NHS hospitals and are likely to accelerate interest in accredited European private hospitals offering rapid access to orthopaedic surgery, spinal treatment and diagnostics at lower prices than many UK private providers.
According to the Telegraph report, British Medical Association figures show that 48 per cent of NHS trusts responding to freedom of information requests are using “advanced practitioners” to cover doctors’ shifts. These practitioners are mostly nurses with further training but may also include pharmacists, paramedics and physiotherapists. The concern raised in the article is not whether advanced practitioners are valuable members of clinical teams, but whether overstretched hospitals are using them to fill roles originally intended for doctors.
The Telegraph also reported that almost a quarter of the trusts surveyed used advanced practitioners to cover registrar shifts. Registrars are senior doctors in the final years of specialist training and are often the most senior doctors on-site below consultant level. For patients already worried about delays, cancellations and overstretched services, these findings add to a wider sense that the NHS is under serious structural pressure.
This matters directly to patients waiting for hip and knee replacement surgery, shoulder and ACL surgery, spinal procedures, diagnostics or specialist consultations. Long NHS waits can mean months of pain, reduced mobility, interrupted work and declining quality of life. At the same time, UK private hospital prices remain out of reach for many families. The result is a growing search for affordable private healthcare abroad, especially in Europe where many hospitals offer consultant-led treatment, modern surgical facilities and fixed-price all-inclusive care packages.
Through MMG, UK patients can access accredited European hospitals offering faster treatment abroad without the uncertainty that often surrounds arranging medical care independently. Patients can compare hospitals, understand pricing, book diagnostic pathways and move towards surgery within weeks of diagnostic clearance. The purpose is simple: to make private treatment abroad easier, safer and more transparent for patients who cannot afford to wait indefinitely.
The Telegraph investigation also highlighted concern about public understanding of clinical roles. In a BMA survey of more than 5,000 doctors, three-quarters reportedly said they did not believe the public understood the difference between doctors and advanced practitioners. That concern goes to the heart of patient confidence. People want to know who is responsible for their care, who is making the final clinical decisions and whether their treatment is being overseen by an appropriately qualified specialist.
One of the advantages of many European private hospital pathways is clarity. Patients know which consultant surgeon or specialist is leading their case from the outset. Treatment plans are reviewed before travel, diagnostic requirements are identified early and three surgery dates within the next six weeks are rapidly offered once medical clearance has been confirmed. For patients searching for lower cost private surgery abroad or alternatives to NHS waiting lists, that combination of speed, transparency and consultant-led care is increasingly compelling.
MMG’s model has been built around exactly this need. The platform connects patients with accredited European hospitals and specialist surgeons while providing fixed-price treatment packages, finance and insurance information, diagnostic coordination and guided booking support. Rather than leaving patients to navigate foreign healthcare systems alone, MMG provides a structured route from enquiry to treatment.
The Daily Telegraph story is another reminder that the UK healthcare debate is no longer only about waiting times. It is also about capacity, workforce pressure, clinical continuity and patient trust. Advanced practitioners play an important role in modern healthcare but even NHS England has stated that they should not replace doctors. For patients, the reassurance comes from knowing that their treatment pathway is properly supervised, clearly explained and led by the right specialist at the right stage.
For many people, private treatment abroad is no longer a niche option. It is becoming a practical healthcare choice. European hospitals in countries such as Spain and Lithuania offer advanced orthopaedic surgery, spinal care, diagnostics and other specialist treatments at prices often significantly below UK private hospital costs. Many also offer shorter waits, modern facilities and rehabilitation pathways designed around international patients.
For thousands of UK patients currently waiting months for diagnostics, orthopaedic surgery or specialist consultations, accredited European hospitals are increasingly becoming the fastest, most affordable and most transparent route to high-quality consultant-led healthcare. MMG exists to make that route simple, supported and accessible.


Leave a comment